Diane M. Cooper
Keine laufenden Positionen mehr
Profil
Diane M.
Cooper worked as a Medical Director at Johnson & Johnson and as a Medical Director & Chief Clinical Officer at Nuvesse Skin Therapies, Inc. She also worked as a Medical Director at Ethicon, Inc. and as a Director of Clinical Affairs at Healthpoint Ltd.
Additionally, she worked as a Principal at Human Genome Sciences, Inc. and NovaBay Pharmaceuticals, Inc. She was also a Faculty Member at Michigan State University, the University of California, San Francisco, and the University of Texas Medical Branch.
Furthermore, she was a Member of The Wound Healing Society.
Dr. Cooper received her graduate degree from the University of Washington, her doctorate from the University of Pennsylvania, and her undergraduate degree from Holy Names University.
Ehemalige bekannte Positionen von Diane M. Cooper
| Unternehmen | Position | Ende |
|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Corporate Officer/Principal | - |
| The Wound Healing Society | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
| University of Texas Medical Branch | Corporate Officer/Principal | - |
Ausbildung von Diane M. Cooper
| University of Washington | Graduate Degree |
| Holy Names University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVABAY PHARMACEUTICALS, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Nuvesse Skin Therapies, Inc.
 Nuvesse Skin Therapies, Inc. Medical DistributorsDistribution Services Nuvesse Skin Therapies, Inc. provides integrated wound management systems and personalized, direct-to-patient treatment solutions. Its products enables clinicians to document care through simple, web- and phone-based assessment tools, and to order personalized antimicrobial wound dressings. The company was founded by Oleg Siniaguine, David A. Richard and Dennis E. Condon in 2004 and is headquartered in Castro Valley, CA. | Distribution Services |
Healthpoint Ltd.
 Healthpoint Ltd. Pharmaceuticals: MajorHealth Technology Healthpoint Ltd. developed and marketed pharmaceutical and medical products. The company was founded in 1992 and was headquartered in Fort Worth, TX. | Health Technology |
Ethicon, Inc.
Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Health Technology |
| The Wound Healing Society | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |